
Adaptive and Efficient Multi-arm Phase 2 Glioblastoma Clinical Trial
Creating an adaptive, effective multi-arm Phase 2 clinical trial for glioblastoma necessitates careful consideration of a number of criteria, including patient population, treatment arms, statistical…










